Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gary R. Pasternack.
Bacteriophage | 2011
Bradley Anderson; Mohammed H. Rashid; Chandi Carter; Gary R. Pasternack; Chythanya Rajanna; Tamara Revazishvili; Timothy R. Dean; Andre Senecal; Alexander Sulakvelidze
Bacteriophages are increasingly being utilized and considered for various practical applications, ranging from decontaminating foods and inanimate surfaces to human therapy; therefore, it is important to determine their concentrations quickly and reliably. Traditional plaque assay (PA) is the current “gold standard” for quantitating phage titers. However, it requires at least 18 h before results are obtained, and they may be significantly influenced by various factors. Therefore, two alternative assays based on the quantitative real-time polymerase chain reaction (QPCR) and NanoSight Limited (NS) technologies were recently proposed for enumerating phage particles. The present study compared the three approaches’ abilities to quantitate Listeria monocytogenes-, Escherichia coli O157:H7-, and Yersinia pestis-specific lytic phages quickly and reproducibly. The average coefficient of variation (CVS) of the PA method including all three phages was 0.15. The reproducibility of the PA method decreased dramatically when multiple investigators performed the assays, and mean differences of as much as 0.33 log were observed. The QPCR method required costly equipment and the synthesis of phage-specific oligonucleotide primers, but it determined phage concentrations faster (within about 4 h) and more precisely than did PA (CVS = 0.13). NS technology required costly equipment, was less precise (CVS = 0.28) than the PA and QPCR methods, and only worked when the phages were suspended in clear medium. However, it provided results within 5 min. After the overall correlation is established with the PA method, either of the two assays may be useful for quickly and reproducibly determining phage concentrations.
Archive | 2001
Alexander Sulakvelidze; J. Morris; Zemphira Alavidze; Gary R. Pasternack; Torrey Brown
Archive | 2001
J. Glenn Morris; Alexander Sulakvelidze; Zemphira Alavidze; Gary R. Pasternack; Torrey Brown
Archive | 2010
Alexander Sulakvelidze; Gary R. Pasternack
Archive | 2001
Alexander Sulakvelidze; J. Morris; Zemphira Alavidze; Gary R. Pasternack; Torrey Brown; Britta Leverentz; William S. Conway; Wojciech J. Janisiewicz
Archive | 2004
Alexander Sulakvelidze; Shanmuga Sozhamamnnan; Gary R. Pasternack
Archive | 2004
Alexander Sulakvelidze; Shanmuga Sozhamamnnan; Gary R. Pasternack
Archive | 2007
Gary R. Pasternack; Alexander Sulakvelidze
Archive | 2007
Gary R. Pasternack; Alexander Sulakvelidze
Archive | 2005
Gary R. Pasternack; Alexander Sulakvelidze